Abstract |
Autoantibody against β1-adrenoceptor (β1-AA) has been shown to be closely linked to the aggravation of heart failure. Removal of β1-AA remarkably attenuated patients' cardiac dysfunction. We found that β1-AA induced rat heart failure with increased CD4+ T cells. However, whether or not β1-AA interacts with T cells isolated from heart failure patients remains unknown. Twenty-one β1-AA-negative heart failure patients were divided into those taking β- adrenergic blocker and those not. The effects of β1-AA monoclonal antibodies (β1-AAmAb) on T cells proliferation were detected using the CCK-8 assay. IFN-γ and IL-4 production by human T cells were measured by after the administration of β1-AAmAb. The levels of cardiomyocyte apoptosis and hypertrophy were detected after co-cultured with the supernatant of T cells pre-stimulated by β1-AAmAb. It was found that β1-AAmAb promoted T cell proliferation via the β1-AR/cAMP/PKA pathway in patients who not take β-blocker. β1-AAmAb inhibited the characteristic cytokine secretion of Th1, IFN-γ, but had no significant effect on the Th2 cytokine IL-4. Supernatant resulted from the T cells pre-treated with β1-AAmAb induced cardiomyocytes remodeling, as evidenced by increased levels of cardiomyocytes apoptosis and hypertrophy. We propose that heart failure is likely to be an interference factor for Th-mediated immunity, and the presence of β1-AAmAb may aggravate this effect and deteriorate concomitant inflammatory injury in cardiomyocytes, partially via β1-AR/cAMP/PKA pathway.
|
Authors | Yunhui Du, Shihan Zhang, Wenjing Hao, Wenli Xu, Li Yan, Huirong Liu |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 510
Issue 1
Pg. 163-170
(02 26 2019)
ISSN: 1090-2104 [Electronic] United States |
PMID | 30678811
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 Elsevier Inc. All rights reserved. |
Chemical References |
- Adrenergic beta-1 Receptor Antagonists
- Autoantibodies
- Receptors, Adrenergic, beta-1
- Cyclic AMP
- Cyclic AMP-Dependent Protein Kinases
|
Topics |
- Adrenergic beta-1 Receptor Antagonists
(administration & dosage, therapeutic use)
- Autoantibodies
(pharmacology)
- Cell Proliferation
(drug effects)
- Coculture Techniques
- Cyclic AMP
(metabolism)
- Cyclic AMP-Dependent Protein Kinases
(metabolism)
- Heart Failure
(immunology, pathology)
- Humans
- Myocytes, Cardiac
(drug effects)
- Receptors, Adrenergic, beta-1
(immunology)
- T-Lymphocytes
(pathology)
- T-Lymphocytes, Helper-Inducer
(immunology)
|